These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11889045)

  • 1. The Wilms' tumor gene Wt1 is required for normal development of the retina.
    Wagner KD; Wagner N; Vidal VP; Schley G; Wilhelm D; Schedl A; Englert C; Scholz H
    EMBO J; 2002 Mar; 21(6):1398-405. PubMed ID: 11889045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b).
    Wagner KD; Wagner N; Schley G; Theres H; Scholz H
    Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
    Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
    Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification.
    Gan L; Wang SW; Huang Z; Klein WH
    Dev Biol; 1999 Jun; 210(2):469-80. PubMed ID: 10357904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1.
    Wilhelm D; Englert C
    Genes Dev; 2002 Jul; 16(14):1839-51. PubMed ID: 12130543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors.
    Xiang M
    Dev Biol; 1998 May; 197(2):155-69. PubMed ID: 9630743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
    FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
    Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
    J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver.
    Kanato K; Hosen N; Yanagihara M; Nakagata N; Shirakata T; Nakazawa T; Nishida S; Tsuboi A; Kawakami M; Masuda T; Oka Y; Oji Y; Ijpenberg A; Hastie ND; Sugiyama H
    Biochem Biophys Res Commun; 2005 Jan; 326(4):836-43. PubMed ID: 15607745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells.
    Wagner N; Wagner KD; Schley G; Coupland SE; Heimann H; Grantyn R; Scholz H
    Cell Growth Differ; 2002 Jul; 13(7):297-305. PubMed ID: 12133898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
    Morrison DJ; English MA; Licht JD
    Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.
    Wagner N; Wagner KD; Theres H; Englert C; Schedl A; Scholz H
    Genes Dev; 2005 Nov; 19(21):2631-42. PubMed ID: 16264195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic interactions between the Wilms' tumor 1 gene and the p53 gene.
    Menke AL; Clarke AR; Leitch A; Ijpenberg A; Williamson KA; Spraggon L; Harrison DJ; Hastie ND
    Cancer Res; 2002 Nov; 62(22):6615-20. PubMed ID: 12438257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
    Smith SI; Down M; Boyd AW; Li CL
    Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.